Takashi Babasaki Selected Research

Takashi Babasaki Research Topics

12	Neoplasms (Cancer) 01/2024 - 01/2020
6	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 08/2019
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 01/2020
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 12/2021
2	Carcinoma (Carcinomatosis) 01/2023 - 03/2022
1	Inflammation (Inflammations) 02/2023
1	Necrosis 10/2022
1	Disease Progression 06/2021
1	Mesothelioma 12/2020
1	Neoplasm Metastasis (Metastasis) 07/2020

5	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2020
3	Sunitinib (Sutent)FDA Link 10/2021 - 04/2020
3	taxaneIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2020
2	Docetaxel (Taxotere)FDA Link 01/2021 - 08/2019
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2020 - 01/2020
1	Heme Oxygenase-1IBA 02/2023
1	Gemcitabine FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Indicators and Reagents (Reagents)IBA 10/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	Pattern Recognition ReceptorsIBA 10/2022
1	PlatinumIBA 02/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Cetuximab (Erbitux)FDA Link 12/2021
1	Aldehyde Dehydrogenase 1 FamilyIBA 12/2021
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 12/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	AdipokinesIBA 12/2020
1	bicalutamide (Casodex)FDA LinkGeneric 10/2020
1	Sorafenib (BAY 43-9006)FDA Link 04/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2020
1	cabazitaxel FDA Link 08/2019

2	Nephrectomy 01/2024 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2023 - 02/2022
2	Castration 01/2021 - 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 11/2023
1	Therapeutics 06/2021
1	Segmental Mastectomy (Lumpectomy) 07/2020
1	Hepatectomy 07/2020